ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
3441 Randomized, open-label, multicenter, phase 3 study of eribulin versus dacarbazine in patients with leiomyosarcoma and adipocytic sarcoma: Health-related quality of life results
European Journal of Cancer
◽
10.1016/s0959-8049(16)31914-1
◽
2015
◽
Vol 51
◽
pp. S702
Author(s):
H. Gelderblom
◽
J.Y. Blay
◽
D. D'Adamo
◽
S. Hudgens
◽
I. Kontoudis
◽
...
Keyword(s):
Quality Of Life
◽
Health Related Quality
◽
Open Label
◽
Phase 3
◽
Multicenter Phase
◽
Related Quality
◽
Health Related
Download Full-text
Related Documents
Cited By
References
Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial
The Lancet Oncology
◽
10.1016/s1470-2045(17)30690-3
◽
2017
◽
Vol 18
(12)
◽
pp. 1600-1609
◽
Cited By ~ 118
Author(s):
Julie R Brahmer
◽
Delvys Rodríguez-Abreu
◽
Andrew G Robinson
◽
Rina Hui
◽
Tibor Csőszi
◽
...
Keyword(s):
Quality Of Life
◽
Health Related Quality
◽
Open Label
◽
Phase 3
◽
Open Label Phase
◽
Related Quality
◽
Health Related
Download Full-text
Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial
The Lancet Oncology
◽
10.1016/s1470-2045(21)00064-4
◽
2021
◽
Author(s):
Thierry Andre
◽
Mayur Amonkar
◽
Josephine M Norquist
◽
Kai-Keen Shiu
◽
Tae Won Kim
◽
...
Keyword(s):
Quality Of Life
◽
Colorectal Cancer
◽
Mismatch Repair
◽
Health Related Quality
◽
First Line
◽
Open Label
◽
Phase 3
◽
Related Quality
◽
Health Related
Download Full-text
Bortezomib, thalidomide, and dexamethasone with or without daratumumab for transplantation-eligible patients with newly diagnosed multiple myeloma (CASSIOPEIA): health-related quality of life outcomes of a randomised, open-label, phase 3 trial
The Lancet Haematology
◽
10.1016/s2352-3026(20)30356-2
◽
2020
◽
Vol 7
(12)
◽
pp. e874-e883
Author(s):
Murielle Roussel
◽
Philippe Moreau
◽
Benjamin Hebraud
◽
Kamel Laribi
◽
Arnaud Jaccard
◽
...
Keyword(s):
Quality Of Life
◽
Newly Diagnosed
◽
Health Related Quality
◽
Life Outcomes
◽
Open Label
◽
Phase 3
◽
Open Label Phase
◽
Related Quality
◽
Health Related
Download Full-text
Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial
The Lancet Oncology
◽
10.1016/s1470-2045(15)00087-x
◽
2015
◽
Vol 16
(13)
◽
pp. 1389-1398
◽
Cited By ~ 122
Author(s):
Jean Jacques Grob
◽
Mayur M Amonkar
◽
Boguslawa Karaszewska
◽
Jacob Schachter
◽
Reinhard Dummer
◽
...
Keyword(s):
Quality Of Life
◽
Combination Therapy
◽
Randomised Trial
◽
Health Related Quality
◽
Open Label
◽
Phase 3
◽
Related Quality
◽
Health Related
Download Full-text
Health-Related Quality of Life in Transplant Ineligible Newly Diagnosed Multiple Myeloma Patients Treated with Either Thalidomide or Lenalidomide-Based Regimen Until Progression (HOVON-87/NMSG18 Study): A Prospective, Open-Label, Multicenter, Randomized, Phase 3 Study
SSRN Electronic Journal
◽
10.2139/ssrn.3337896
◽
2019
◽
Author(s):
Lene Kongsgaard Nielsen
◽
Claudia Stege
◽
Birgit Lissenberg-Witte
◽
Bronno van der Holt
◽
Ulf-Henrik Mellqvist
◽
...
Keyword(s):
Quality Of Life
◽
Multiple Myeloma
◽
Newly Diagnosed
◽
Health Related Quality
◽
Open Label
◽
Phase 3
◽
Related Quality
◽
Health Related
Download Full-text
Health-related quality of life and neurocognitive functioning with lomustine–temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial
The Lancet Oncology
◽
10.1016/s1470-2045(19)30502-9
◽
2019
◽
Vol 20
(10)
◽
pp. 1444-1453
◽
Cited By ~ 4
Author(s):
Johannes Weller
◽
Theophilos Tzaridis
◽
Frederic Mack
◽
Joachim Peter Steinbach
◽
Uwe Schlegel
◽
...
Keyword(s):
Quality Of Life
◽
Neurocognitive Functioning
◽
Newly Diagnosed
◽
Health Related Quality
◽
Open Label
◽
Phase 3
◽
Open Label Phase
◽
Related Quality
◽
Health Related
Download Full-text
Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression: a prospective, open-label, multicenter, randomized, phase 3 study
Haematologica
◽
10.3324/haematol.2019.222299
◽
2019
◽
Vol 105
(6)
◽
pp. 1650-1659
◽
Cited By ~ 2
Author(s):
Lene Kongsgaard Nielsen
◽
Claudia Stege
◽
Birgit Lissenberg-Witte
◽
Bronno van der Holt
◽
Ulf-Henrik Mellqvist
◽
...
Keyword(s):
Quality Of Life
◽
Multiple Myeloma
◽
Newly Diagnosed
◽
Health Related Quality
◽
Open Label
◽
Phase 3
◽
Related Quality
◽
Health Related
Download Full-text
Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
The Lancet Oncology
◽
10.1016/s1470-2045(16)30305-9
◽
2016
◽
Vol 17
(11)
◽
pp. 1533-1542
◽
Cited By ~ 58
Author(s):
Jaap C Reijneveld
◽
Martin J B Taphoorn
◽
Corneel Coens
◽
Jacoline E C Bromberg
◽
Warren P Mason
◽
...
Keyword(s):
Quality Of Life
◽
High Risk
◽
Low Grade
◽
Health Related Quality
◽
Open Label
◽
Phase 3
◽
Open Label Phase
◽
Related Quality
◽
Health Related
Download Full-text
Health-related quality of life in acute schizophrenia patients treated with RBP-7000 once monthly risperidone: An 8-week, randomized, double-blind, placebo-controlled, multicenter phase 3 study
Schizophrenia Research
◽
10.1016/j.schres.2016.03.020
◽
2016
◽
Vol 174
(1-3)
◽
pp. 126-131
◽
Cited By ~ 10
Author(s):
John J. Isitt
◽
Vijay R. Nadipelli
◽
Alex Kouassi
◽
Maurizio Fava
◽
Christian Heidbreder
Keyword(s):
Quality Of Life
◽
Health Related Quality
◽
Phase 3
◽
Double Blind
◽
Double Blind Placebo
◽
Acute Schizophrenia
◽
Multicenter Phase
◽
Related Quality
◽
Health Related
Download Full-text
EFFECT OF DARATUMUMAB, BORTEZOMIB, CYCLOPHOSPHAMIDE, AND DEXAMETHASONE ON CARDIAC FUNCTION AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH NEWLY-DIAGNOSED AL AMYLOIDOSIS WITH CARDIAC INVOLVEMENT: RESULTS FROM THE PHASE 3 ANDROMEDA STUDY
Journal of the American College of Cardiology
◽
10.1016/s0735-1097(21)04658-1
◽
2021
◽
Vol 77
(18)
◽
pp. 3304
Author(s):
Martha Grogan
◽
Mathew S. Maurer
◽
Ronald Witteles
◽
Divaya Bhutani
◽
Raymond L. Comenzo
◽
...
Keyword(s):
Quality Of Life
◽
Cardiac Function
◽
Cardiac Involvement
◽
Al Amyloidosis
◽
Newly Diagnosed
◽
Health Related Quality
◽
Phase 3
◽
Related Quality
◽
Health Related
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close